Targeted RNA-Based Oxford Nanopore Sequencing for Typing 12 Classical HLA Genes.

HLA genotyping MinION RNA sequencing human leukocyte antigen nanopore sequencing

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2021
Historique:
received: 30 11 2020
accepted: 11 02 2021
entrez: 25 3 2021
pubmed: 26 3 2021
medline: 26 3 2021
Statut: epublish

Résumé

Identification of human leukocyte antigen (HLA) alleles from next-generation sequencing (NGS) data is challenging because of the high polymorphism and mosaic nature of HLA genes. Owing to the complex nature of HLA genes and consequent challenges in allele assignment, Oxford Nanopore Technologies' (ONT) single-molecule sequencing technology has been of great interest due to its fitness for sequencing long reads. In addition to the read length, ONT's advantages are its portability and possibility for a rapid real-time sequencing, which enables a simultaneous data analysis. Here, we describe a targeted RNA-based method for HLA typing using ONT sequencing and SeqNext-HLA SeqPilot software (JSI Medical Systems GmbH). Twelve classical HLA genes were enriched from cDNA of 50 individuals, barcoded, pooled, and sequenced in 10 MinION R9.4 SpotON flow cell runs producing over 30,000 reads per sample. Using barcoded 2D reads, SeqPilot assigned HLA alleles to two-field typing resolution or higher with the average read depth of 1750x. Sequence analysis resulted in 99-100% accuracy at low-resolution level (one-field) and in 74-100% accuracy at high-resolution level (two-field) with the expected alleles. There are still some limitations with ONT RNA sequencing, such as noisy reads, homopolymer errors, and the lack of robust algorithms, which interfere with confident allele assignment. These issues need to be inspected carefully in the future to improve the allele call rates. Nevertheless, here we show that sequencing of multiplexed cDNA amplicon libraries on ONT MinION can produce accurate high-resolution typing results of 12 classical HLA loci. For HLA research, ONT RNA sequencing is a promising method due to its capability to sequence full-length HLA transcripts. In addition to HLA genotyping, the technique could also be applied for simultaneous expression analysis.

Identifiants

pubmed: 33763116
doi: 10.3389/fgene.2021.635601
pmc: PMC7982845
doi:

Types de publication

Journal Article

Langues

eng

Pagination

635601

Informations de copyright

Copyright © 2021 Johansson, Koskela, Yohannes, Partanen and Saavalainen.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Gigascience. 2014 Oct 20;3:22
pubmed: 25386338
J Mol Diagn. 2020 Jan;22(1):101-110
pubmed: 31669229
F1000Res. 2017 May 31;6:760
pubmed: 28794860
Genes Immun. 2014 Mar;15(2):133-6
pubmed: 24304973
Tissue Antigens. 2013 Jan;81(1):35-43
pubmed: 23216287
BMC Genomics. 2011 Jan 18;12:42
pubmed: 21244689
Science. 2013 Apr 5;340(6128):87-91
pubmed: 23559252
BMC Genomics. 2012 Aug 06;13:378
pubmed: 22866951
N Engl J Med. 2015 Aug 13;373(7):599-609
pubmed: 26267621
Front Genet. 2018 Apr 30;9:152
pubmed: 29760718
Science. 2018 Jan 5;359(6371):86-90
pubmed: 29302013
Tissue Antigens. 2012 Oct;80(4):305-16
pubmed: 22861646
Nat Protoc. 2012 Apr 05;7(5):813-28
pubmed: 22481528
Nat Genet. 2019 Mar;51(3):470-480
pubmed: 30692682
Genome Med. 2012 Dec 22;4(12):102
pubmed: 23259685
J Med Genet. 2016 Oct;53(10):681-9
pubmed: 27287392
PLoS One. 2015 May 27;10(5):e0127153
pubmed: 26018555
J Clin Oncol. 2020 Aug 20;38(24):2712-2718
pubmed: 32479188
Bioinformatics. 2020 Jan 1;36(1):33-40
pubmed: 31173059
Nature. 1999 Oct 28;401(6756):921-3
pubmed: 10553908
Blood. 2014 Dec 18;124(26):3996-4003
pubmed: 25323824
J Mol Diagn. 2018 Jul;20(4):428-435
pubmed: 29625249
Hum Immunol. 2020 May 1;:
pubmed: 32386782
HLA. 2020 Aug;96(2):141-162
pubmed: 32274854
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9942-E9951
pubmed: 29093164
Genome Med. 2017 Sep 27;9(1):86
pubmed: 28954626
Sci Transl Med. 2017 May 10;9(389):
pubmed: 28490672
HLA. 2018 Feb;91(2):88-101
pubmed: 29171935
Bioinformatics. 2016 Jan 1;32(1):142-4
pubmed: 26382197
Genome Med. 2012 Dec 10;4(12):95
pubmed: 23228053
Nat Biotechnol. 2018 Apr;36(4):338-345
pubmed: 29431738
Nat Rev Genet. 2004 Dec;5(12):889-99
pubmed: 15573121
HLA. 2020 Aug;96(2):163-178
pubmed: 32419382
Biol Blood Marrow Transplant. 2019 Mar;25(3):443-450
pubmed: 30935664

Auteurs

Tiira Johansson (T)

Translational Immunology Research Program and Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
Finnish Red Cross Blood Service, Helsinki, Finland.

Satu Koskela (S)

Finnish Red Cross Blood Service, Helsinki, Finland.

Dawit A Yohannes (DA)

Translational Immunology Research Program and Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.

Jukka Partanen (J)

Finnish Red Cross Blood Service, Helsinki, Finland.

Päivi Saavalainen (P)

Translational Immunology Research Program and Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
Finnish Red Cross Blood Service, Helsinki, Finland.

Classifications MeSH